This difference aligns with familiar patterns of higher insulin resistance and slower fat mobilization in type 2 diabetes
Theres a perception that if a drug isn't approved, that just means its not approved yet
What I Learned the Hard Way I will be straightforward: I have not had a dramatic fueling failure on GLP-1 because I approached race nutrition cautiously from the start
Patients who take these drugs long-term can lose more than 15% of their body weight and experience major improvements in blood-sugar control, with reduced risks of heart attacks, strokes, chronic kidney disease, sleep apnea and other obesity-related complications
If your anticoagulation is managed by a cardiologist or hematologist, ensure they are also aware you are beginning GLP-1 therapy so they can advise on monitoring frequency
During the titration phase (weeks 1-20), participants often see gradual weight loss of 1-2 pounds per week as doses are increased, reduced appetite and food cravings within the first 2-4 weeks, improved satiety and easier adherence to reduced-calorie diets, and early body gains (better glucose control, reduced blood pressure)
